{"title":"RAS in lung transplantation - Renin-Angiotensin System and mitochondrial protection with Angiotensin-1-7 during pulmonary preservation at 10°C.","authors":"Ilker Iskender,Clemens Aigner","doi":"10.1016/j.healun.2025.08.009","DOIUrl":"https://doi.org/10.1016/j.healun.2025.08.009","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144930168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Donation after circulatory death heart transplantation in the United States continues to steadily increase but maintains unrealized potential to address the organ shortage.","authors":"A Cozette Killian,Rajamiyer Venkateswaran","doi":"10.1016/j.healun.2025.08.006","DOIUrl":"https://doi.org/10.1016/j.healun.2025.08.006","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144930167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alberto Benazzo,John Peel,Andrea Mariscal,Jonathan Yeung,Meghan Aversa,Shaf Keshavjee,Marcelo Cypel
{"title":"Differential outcomes of ISHLT PGD 3 after ex-vivo lung perfusion compared to PGD 3 after direct transplantation.","authors":"Alberto Benazzo,John Peel,Andrea Mariscal,Jonathan Yeung,Meghan Aversa,Shaf Keshavjee,Marcelo Cypel","doi":"10.1016/j.healun.2025.08.002","DOIUrl":"https://doi.org/10.1016/j.healun.2025.08.002","url":null,"abstract":"BACKGROUNDPrimary graft dysfunction (PGD) remains the most feared complication in the early postoperative period after lung transplantation (LTx). Despite improved evaluation of marginal lungs with ex-vivo lung perfusion (EVLP), PGD 3 is still observed. We aimed to evaluate the outcomes of patients developing PGD 3 after EVLP.METHODSThis is a retrospective single-center study, including patients who received LTx between 2008 and 2021 in the Toronto Lung Transplant Program. The primary end-point was 90-day mortality. Propensity score weighting was applied to correct for possible confounders.RESULTSThe final analysis included 1,871 patients, of which 538 lungs were transplanted after EVLP assessment using the Toronto EVLP technique. The incidence of grade 3 PGD was 38.1% and 20.8% (p < 0.001) on intensive care unit (ICU) admission and 13.2% and 12.1% (p = 0.445) at 72 hours for EVLP LTx and standard transplantation, respectively. The EVLP LTx group developing PGD 3 on arrival to ICU had a shorter median length of mechanical ventilation (82 vs 124 hours, p < 0.001), shorter length of stay in ICU (6 vs 12 days, p < 0.001), and shorter length of hospital stay (23 vs 41 days, p < 0.001) compared to standard LTx PGD 3 group. A lower 90-day mortality rate in the EVLP LTx group was observed compared to standard LTx (6% vs 11%, p = 0.078). Mortality rate at 1 year post-transplant for PGD 3 patients was similar between the groups.CONCLUSIONSThe incidence of PGD 3 on admission to the ICU is higher after EVLP compared to standard transplantation. However, PGD 3 after acellular normothermic EVLP resolves within 24 hours and short-term outcomes are significantly improved compared to patients with PGD 3 after standard transplantation.","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144930215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Extracorporeal membrane oxygenation in cardiogenic shock: A bridge in need of a destination.","authors":"Jacob C Jentzer","doi":"10.1016/j.healun.2025.07.034","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.034","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144930166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The kidneys' effect on the survival of multi-organ transplant recipients.","authors":"Richard N Formica","doi":"10.1016/j.healun.2025.07.031","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.031","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"66 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144930169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Suraj Nagaraj,Amy Suhotliv,Shreyas Yakkali,Kate Steinberg,Ulrich P Jorde,Harrison Farber,Sandhya Murthy
{"title":"Hemodynamic Effects of Sotatercept Administration in Pulmonary Hypertension- Insights from Remote Monitoring.","authors":"Suraj Nagaraj,Amy Suhotliv,Shreyas Yakkali,Kate Steinberg,Ulrich P Jorde,Harrison Farber,Sandhya Murthy","doi":"10.1016/j.healun.2025.07.032","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.032","url":null,"abstract":"Although there has been considerable momentum in the field of pulmonary arterial hypertension (PAH) over the past few decades, it remains an incurable disease. Sotatercept is a novel agent that favors pro-apoptotic pathways within the pulmonary artery by way of complex signaling. This unique remodeling mechanism is distinct from traditional vasodilator therapy, as it attempts to address the underpinning pathophysiology of PAH. It was recently approved as an adjunct to traditional vasodilator therapies in non-low risk patients. We describe our early hemodynamic experience with Sotatercept in a series of patients implanted with a pulmonary artery sensor system (CardioMEMSTM). Through weekly remote transmissions, we describe the rapid hemodynamic improvement observed in our cohort.","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144792021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"First Come, Second Served: Behind the Veil of Out-of-Sequence Donors in Adult Heart Transplant.","authors":"Yasbanoo Moayedi,Heather Ross","doi":"10.1016/j.healun.2025.07.026","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.026","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144792066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth J Bashian,Sarah Y Park,Rocio Lopez,Jesse D Schold,Nicholas R Teman,Michael T Cain,Jordan R H Hoffman
{"title":"Donation after Circulatory Death Transplantation Alleviate Waitlist Time for Hard-to-Transplant Cardiac Recipients.","authors":"Elizabeth J Bashian,Sarah Y Park,Rocio Lopez,Jesse D Schold,Nicholas R Teman,Michael T Cain,Jordan R H Hoffman","doi":"10.1016/j.healun.2025.07.017","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.017","url":null,"abstract":"PURPOSEDonation after circulatory death (DCD) can increase the cardiac transplant donor pool and decrease waitlist time. Patients with certain characteristics may be more difficult to match with appropriate donors. This study aimed to evaluate the impact of DCD heart donations on these candidates.METHODSThis was a retrospective study using the Scientific Registry of Transplant Recipients database including adult patients listed for heart transplant between 11/1/2018 and 3/2/2024. The cohort was divided into pre-DCD era, early DCD era, and contemporary DCD era. The following factors were used to classify candidates as difficult to transplant: height or weight greater than 2 SD above the average, blood type O, congenital heart disease, LVAD, and status 4, 5, or 6.RESULTSFindings revealed a decrease in median waitlist time from 2.8 months in the pre-DCD era to 1.6 months in the contemporary era and an increase in the transplantation rate from 65% to 73%. However, factors such as type O blood, presence of durable left ventricular assist devices (LVAD), and listing status significantly correlated with lower transplant likelihood across eras. DCD transplant recipients faced longer waitlist times compared to donation after brain death (DBD) counterparts in the early DCD era, while this disparity diminished in the contemporary era.CONCLUSIONSEarly DCD utilization alleviated the prolonged waiting times seen by hard-to-transplant recipients. As experience with DCD hearts increased, DCD hearts augmented the donor pool, reducing waitlist time in across all cohorts.","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144766001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Transplanting Beyond Anatomy: When Congenital Heart Disease Challenges Persist Despite a New Heart.","authors":"Nicola Pradegan,Gino Gerosa","doi":"10.1016/j.healun.2025.07.025","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.025","url":null,"abstract":"","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144763552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paolo Oliveira,Aizhou Wang,Keiji Yamanashi,Yu Zhang,Prodipto Pal,Guillermo Garza,Juan Montagne,Gabriel Siebiger,Nadav Furie,Jenny Yune,Shaf Keshavjee,Paulo Manuel Pêgo-Fernandes,Marcelo Cypel
{"title":"Angiotensin-(1-7) preconditioning during 10°C static preservation improves early post-transplant graft function in a rat lung transplantation model.","authors":"Paolo Oliveira,Aizhou Wang,Keiji Yamanashi,Yu Zhang,Prodipto Pal,Guillermo Garza,Juan Montagne,Gabriel Siebiger,Nadav Furie,Jenny Yune,Shaf Keshavjee,Paulo Manuel Pêgo-Fernandes,Marcelo Cypel","doi":"10.1016/j.healun.2025.07.018","DOIUrl":"https://doi.org/10.1016/j.healun.2025.07.018","url":null,"abstract":"BACKGROUNDIschemia-reperfusion injury (IRI) plays an important role in early graft failure after lung transplantation. We hypothesized that treating injured donor lungs with Angiotensin-(1-7) [Ang-(1-7)], a biologically active product of the protective axis of the renin-angiotensin system, during 10°C preservation reduces IRI and improves lung transplant outcomes.METHODSIn Lewis rats, aspiration injury was induced through intratracheal instillation of hydrochloric acid (0.1N). Acid injured donor lungs (n = 5/group) were randomized to lungs flushed with low-potassium dextran-glucose solution (LPDG; Control) or LPDG plus Ang-(1-7) and stored for 12 hours at 10ºC. A third group included immediate transplantation (MinCIT). Left lungs were transplanted and reperfused for 2 hours.RESULTSAfter transplantation, lungs preconditioned with Ang-(1-7) showed significantly better oxygenation (p = 0.004) and lower IL-8 levels (p = 0.01) compared to other groups. Results of a panel of mitochondrial biogenesis markers showed higher fold regulations for MFN2 (p = 0.03), when lungs were flushed with Ang-(1-7) relative to Control. The improvement in lung function was dependent on MasR activation and specific to 10°C preservation.CONCLUSIONSWe demonstrate that the enrichment of lung preservation flush solution with Ang-(1-7) results in superior post-transplant graft function, amplifying the beneficial effects of hypothermic preservation on injured lungs. The maintenance of mitochondrial and cellular health through preconditioning with Ang-(1-7) may result in better clinical outcomes.","PeriodicalId":22654,"journal":{"name":"The Journal of Heart and Lung Transplantation","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144763232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}